Global Therapeutic Nuclear Medicines Competitive Landscape Professional Research Report 2025
Description
Global Therapeutic Nuclear Medicines Competitive Landscape Professional Research Report 2025
Research Summary
Therapeutic nuclear medicine involves the use of radioactive substances, known as radiopharmaceuticals, for the treatment of various medical conditions. Unlike diagnostic nuclear medicine, which focuses on imaging techniques to visualize internal structures and functions, therapeutic nuclear medicine employs radioactive materials to deliver targeted doses of radiation to specific tissues or organs to treat diseases. Common applications of therapeutic nuclear medicine include the treatment of certain types of cancer, such as thyroid cancer, lymphoma, and bone metastases, as well as non-cancerous conditions like hyperthyroidism and certain types of arthritis. Radiopharmaceuticals used in therapeutic nuclear medicine emit radiation that can selectively destroy or inhibit the growth of abnormal cells while minimizing damage to surrounding healthy tissues. This approach allows for precise and localized treatment, often with fewer side effects compared to traditional therapies. Therapeutic nuclear medicine plays a significant role in modern medicine, offering effective treatment options for a wide range of conditions.
According to DIResearch's in-depth investigation and research, the global Therapeutic Nuclear Medicines market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Therapeutic Nuclear Medicines include Novartis AG, Bayer, China Isotope & Radiation, Q BioMed, Curium Pharmaceuticals, Jubilant DraxImage, Dongcheng, Lantheus, Acrotech Biopharma., Progenics Pharmaceuticals, International Isotopes etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Therapeutic Nuclear Medicines. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Therapeutic Nuclear Medicines market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Therapeutic Nuclear Medicines market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Therapeutic Nuclear Medicines industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Therapeutic Nuclear Medicines Include:
Novartis AG
Bayer
China Isotope & Radiation
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Dongcheng
Lantheus
Acrotech Biopharma.
Progenics Pharmaceuticals
International Isotopes
Therapeutic Nuclear Medicines Product Segment Include:
Radium-223
Lutetium-177
Iodine-131
Other
Therapeutic Nuclear Medicines Product Application Include:
Thyroid
Bone Metastasis
Lymphoma
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Therapeutic Nuclear Medicines Industry PESTEL Analysis
Chapter 3: Global Therapeutic Nuclear Medicines Industry Porter’s Five Forces Analysis
Chapter 4: Global Therapeutic Nuclear Medicines Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global Therapeutic Nuclear Medicines Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Therapeutic Nuclear Medicines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Therapeutic Nuclear Medicines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Therapeutic Nuclear Medicines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Therapeutic Nuclear Medicines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Therapeutic Nuclear Medicines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Therapeutic Nuclear Medicines Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Therapeutic Nuclear Medicines Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents
170 Pages
- 1 Therapeutic Nuclear Medicines Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Therapeutic Nuclear Medicines Product by Type
- 1.2.1 Radium-223
- 1.2.2 Lutetium-177
- 1.2.3 Iodine-131
- 1.2.4 Other
- 1.3 Therapeutic Nuclear Medicines Product by Application
- 1.3.1 Thyroid
- 1.3.2 Bone Metastasis
- 1.3.3 Lymphoma
- 1.3.4 Other
- 1.4 Global Therapeutic Nuclear Medicines Market Revenue and Sales Analysis
- 1.4.1 Global Therapeutic Nuclear Medicines Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Therapeutic Nuclear Medicines Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Therapeutic Nuclear Medicines Market Sales Price Trend Analysis (2020-2032)
- 1.5 Therapeutic Nuclear Medicines Industry Trends and Innovation
- 1.5.1 Therapeutic Nuclear Medicines Industry Trends and Innovation
- 1.5.2 Therapeutic Nuclear Medicines Market Drivers and Challenges
- 2 Therapeutic Nuclear Medicines Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Therapeutic Nuclear Medicines Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Therapeutic Nuclear Medicines Market Analysis by Regions
- 4.1 Therapeutic Nuclear Medicines Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Therapeutic Nuclear Medicines Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Therapeutic Nuclear Medicines Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Therapeutic Nuclear Medicines Revenue and Market Share Forecast by Region (2026-2032)
- 4.3 Global Therapeutic Nuclear Medicines Sales and Forecast Analysis (2020-2032)
- 4.3.1 Global Therapeutic Nuclear Medicines Sales and Market Share by Region (2020-2025)
- 4.3.2 Global Therapeutic Nuclear Medicines Sales Forecast by Region (2026-2032)
- 4.4 Global Therapeutic Nuclear Medicines Sales Price Trend Analysis (2020-2032)
- 5 Global Therapeutic Nuclear Medicines Market Size by Type and Application
- 5.1 Global Therapeutic Nuclear Medicines Market Size by Type
- 5.1.1 Global Therapeutic Nuclear Medicines Revenue and Forecast Analysis by Type (2020-2032)
- 5.1.2 Global Therapeutic Nuclear Medicines Sales and Forecast Analysis by Type (2020-2032)
- 5.2 Global Therapeutic Nuclear Medicines Market Size by Application
- 5.2.1 Global Therapeutic Nuclear Medicines Revenue and Forecast Analysis by Application (2020-2032)
- 5.2.2 Global Therapeutic Nuclear Medicines Sales and Forecast Analysis by Application (2020-2032)
- 6 North America
- 6.1 North America Therapeutic Nuclear Medicines Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Therapeutic Nuclear Medicines Market Size by Type
- 6.3.1 North America Therapeutic Nuclear Medicines Sales by Type (2020-2032)
- 6.3.2 North America Therapeutic Nuclear Medicines Revenue by Type (2020-2032)
- 6.4 North America Therapeutic Nuclear Medicines Market Size by Application
- 6.4.1 North America Therapeutic Nuclear Medicines Sales by Application (2020-2032)
- 6.4.2 North America Therapeutic Nuclear Medicines Revenue by Application (2020-2032)
- 6.5 North America Therapeutic Nuclear Medicines Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Therapeutic Nuclear Medicines Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Therapeutic Nuclear Medicines Market Size by Type
- 7.3.1 Europe Therapeutic Nuclear Medicines Sales by Type (2020-2032)
- 7.3.2 Europe Therapeutic Nuclear Medicines Revenue by Type (2020-2032)
- 7.4 Europe Therapeutic Nuclear Medicines Market Size by Application
- 7.4.1 Europe Therapeutic Nuclear Medicines Sales by Application (2020-2032)
- 7.4.2 Europe Therapeutic Nuclear Medicines Revenue by Application (2020-2032)
- 7.5 Europe Therapeutic Nuclear Medicines Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Therapeutic Nuclear Medicines Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Therapeutic Nuclear Medicines Market Size by Type
- 8.3.1 China Therapeutic Nuclear Medicines Sales by Type (2020-2032)
- 8.3.2 China Therapeutic Nuclear Medicines Revenue by Type (2020-2032)
- 8.4 China Therapeutic Nuclear Medicines Market Size by Application
- 8.4.1 China Therapeutic Nuclear Medicines Sales by Application (2020-2032)
- 8.4.2 China Therapeutic Nuclear Medicines Revenue by Application (2020-2032)
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Therapeutic Nuclear Medicines Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Therapeutic Nuclear Medicines Market Size by Type
- 9.3.1 APAC (excl. China) Therapeutic Nuclear Medicines Sales by Type (2020-2032)
- 9.3.2 APAC (excl. China) Therapeutic Nuclear Medicines Revenue by Type (2020-2032)
- 9.4 APAC (excl. China) Therapeutic Nuclear Medicines Market Size by Application
- 9.4.1 APAC (excl. China) Therapeutic Nuclear Medicines Sales by Application (2020-2032)
- 9.4.2 APAC (excl. China) Therapeutic Nuclear Medicines Revenue by Application (2020-2032)
- 9.5 APAC (excl. China) Therapeutic Nuclear Medicines Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Therapeutic Nuclear Medicines Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Therapeutic Nuclear Medicines Market Size by Type
- 10.3.1 Latin America Therapeutic Nuclear Medicines Sales by Type (2020-2032)
- 10.3.2 Latin America Therapeutic Nuclear Medicines Revenue by Type (2020-2032)
- 10.4 Latin America Therapeutic Nuclear Medicines Market Size by Application
- 10.4.1 Latin America Therapeutic Nuclear Medicines Sales by Application (2020-2032)
- 10.4.2 Latin America Therapeutic Nuclear Medicines Revenue by Application (2020-2032)
- 10.5 Latin America Therapeutic Nuclear Medicines Market Size by Country
- 10.6 Latin America Therapeutic Nuclear Medicines Market Size by Country
- 10.6.1 Mexico
- 10.6.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Therapeutic Nuclear Medicines Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Therapeutic Nuclear Medicines Market Size by Type
- 11.3.1 Middle East & Africa Therapeutic Nuclear Medicines Sales by Type (2020-2032)
- 11.3.2 Middle East & Africa Therapeutic Nuclear Medicines Revenue by Type (2020-2032)
- 11.4 Middle East & Africa Therapeutic Nuclear Medicines Market Size by Application
- 11.4.1 Middle East & Africa Therapeutic Nuclear Medicines Sales by Application (2020-2032)
- 11.4.2 Middle East & Africa Therapeutic Nuclear Medicines Revenue by Application (2020-2032)
- 11.5 Middle East Therapeutic Nuclear Medicines Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Therapeutic Nuclear Medicines Market Sales, Revenue and Price by Key Manufacturers (2021-2025)
- 12.1.1 Global Therapeutic Nuclear Medicines Market Sales by Key Manufacturers (2021-2025)
- 12.1.2 Global Therapeutic Nuclear Medicines Market Revenue by Key Manufacturers (2021-2025)
- 12.1.3 Global Therapeutic Nuclear Medicines Average Sales Price by Manufacturers (2021-2025)
- 12.2 Therapeutic Nuclear Medicines Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Therapeutic Nuclear Medicines Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Novartis AG
- 13.1.1 Novartis AG Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Novartis AG Therapeutic Nuclear Medicines Product Portfolio
- 13.1.3 Novartis AG Therapeutic Nuclear Medicines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.2 Bayer
- 13.2.1 Bayer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Bayer Therapeutic Nuclear Medicines Product Portfolio
- 13.2.3 Bayer Therapeutic Nuclear Medicines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.3 China Isotope & Radiation
- 13.3.1 China Isotope & Radiation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 China Isotope & Radiation Therapeutic Nuclear Medicines Product Portfolio
- 13.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.4 Q BioMed
- 13.4.1 Q BioMed Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 Q BioMed Therapeutic Nuclear Medicines Product Portfolio
- 13.4.3 Q BioMed Therapeutic Nuclear Medicines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.5 Curium Pharmaceuticals
- 13.5.1 Curium Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Curium Pharmaceuticals Therapeutic Nuclear Medicines Product Portfolio
- 13.5.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.6 Jubilant DraxImage
- 13.6.1 Jubilant DraxImage Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Jubilant DraxImage Therapeutic Nuclear Medicines Product Portfolio
- 13.6.3 Jubilant DraxImage Therapeutic Nuclear Medicines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.7 Dongcheng
- 13.7.1 Dongcheng Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 Dongcheng Therapeutic Nuclear Medicines Product Portfolio
- 13.7.3 Dongcheng Therapeutic Nuclear Medicines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.8 Lantheus
- 13.8.1 Lantheus Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Lantheus Therapeutic Nuclear Medicines Product Portfolio
- 13.8.3 Lantheus Therapeutic Nuclear Medicines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.9 Acrotech Biopharma.
- 13.9.1 Acrotech Biopharma. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Acrotech Biopharma. Therapeutic Nuclear Medicines Product Portfolio
- 13.9.3 Acrotech Biopharma. Therapeutic Nuclear Medicines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.10 Progenics Pharmaceuticals
- 13.10.1 Progenics Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product Portfolio
- 13.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 13.11 International Isotopes
- 13.11.1 International Isotopes Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 International Isotopes Therapeutic Nuclear Medicines Product Portfolio
- 13.11.3 International Isotopes Therapeutic Nuclear Medicines Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Therapeutic Nuclear Medicines Industry Chain Analysis
- 14.2 Therapeutic Nuclear Medicines Industry Raw Material and Suppliers Analysis
- 14.2.1 Therapeutic Nuclear Medicines Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Therapeutic Nuclear Medicines Typical Downstream Customers
- 14.4 Therapeutic Nuclear Medicines Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
